Table of Contents
Basic Research
| Optimizing the methods of whole lung cancer RNA-loaded dendritic cells | |
| Kun WANG, Yilong WU, Qing ZHOU, Chongrui XU, Jiaying LIN, Xuening YANG, Shaoqiong HUANG | 489-494 |
| Inhibition of human lung adenocarcinoma cells by 5F11-doxorubicin immunoconjugate in vitro and in vivo | |
| Tongmei ZHANG, Baitang LAI, Xiuping ZHAN | 495-500 |
| Inhibition of mouse Lewis lung cancer via intravenous administration of recombinant mouse sFlt1 adenovirus | |
| Bing KAN, Yu JIANG, Jinliang YANG, Xiancheng CHEN, Min HU, Yuquan WEI | 501-503 |
| Effects of targeting inhibition of ERK1/2 signal transduction pathway on malignant biological behaviors of human high-metastatic large cell lung cancer cell line L9981 | |
| Yin LI, Qinghua ZHOU, Zhilin SUN, Zefang SUN, Yanping WANG, Yang QIN, Wen ZHU, Xiaohe CHEN | 504-509 |
| Effects of bisphosphonates on proliferation of lung cancer cells in vitro | |
| Xiufeng LIN, Huixin YU, Cheng TAN, Bo CHEN, Tiesheng WANG, Bocheng WANG | 510-513 |
Epidemiology
| The morbidity and mortality trend and prediction of lung cancer in residents of Nangang District of Harbin in China during the past 10 years | |
| Xiwen SUN, Wei LIU, Shuling WU, Huili HAN, Yingji LIN, Xudong DAI | 514-517 |
Clinical Research
| Expression of Kai1 and FasL in non-small cell lung cancer and its clinicopathological significance | |
| Yuanhang LI, Dongying WU, Huachuan ZHENG, Yan XIN | 518-522 |
| Expression of multiple drug resistance-associated proteins in non-small cell lung cancer tissues and its clinical significance | |
| Changlin LI, Mei HOU, Yu ZHAO, Qinghua ZHOU | 523-526 |
| A preliminary result of radioactivity 125I seed implants with micropuncture technique combined with chemotherapy in the treatment of stage Ⅲ and Ⅳ lung cancer | |
| Gaifa FU, Guangyan LEI, Xinkuan BAI, Zhulian ZHAO, Yangrong SONG, Xuewu ZHAO | 527-529 |
| A randomized clinical trial of gemcitabine plus cisplatin compared with gemcitabine plus vinorelbine in the treatment of non-small cell lung cancer | |
| Li ZHANG, Ning LI, Fei XU, Yang ZHANG | 530-534 |
| Evaluation on survival in locally advanced non-small cell lung cancer (NSCLC) for multimodality treatment with or without operation | |
| Jinhan LI, Shudong MA, Shijun KANG, Jianming XIE, Xinxiu SHENG, Rongcheng LUO | 535-537 |
| A randomized clinical trial of chemotherapy combined with oxaliplatin and cisplatin plus navelbine in the treatment of advanced non-small cell lung cancer | |
| Li REN, Jiang ZHU, Hongfeng GOU, Xi YAN, Jianping HE | 538-541 |
| Clinical analysis of 58 surgically treated patients with bronchioloalveolar carcinoma | |
| Jianbo WU, Taoyuan LI, Li DIAO | 542-543 |
Clinical Experience
| 肿瘤标志物联合检测在肺癌诊治中的价值 | |
| 郭 林, 左 桂兰, 许 晓峰, 蒋 国樑, 傅 小龙 | 544-546 |
| 局部晚期非小细胞肺癌同步放化疗随机对照临床试验 | |
| 孙 志华, 于 世英, 刘 英杰, 王 婷 | 547-549 |
| 肺间质纤维化合并肺癌四例临床经验总结 | |
| 吴 驰, 杨 先锋, 李 龙芸 | 550-552 |
Nursing Practice
| 肺癌合并上腔静脉综合征的化疗护理 | |
| 向 秋芬, 李 俊英, 汪 娟 | 553-554 |
| 伊立替康为主联合治疗晚期肺癌的护理 | |
| 袁 灵, 李 虹, 刁 永书 | 555-556 |
Minireview
| 中国肺癌外科治疗概况与进展 | |
| 张 德超, 毛 友生, 黄 国俊 | 557-562 |
| SSH技术及其在肿瘤研究中的应用 | |
| 马 家宝, 周 清华 | 563-566 |
| 肺癌与COX-2的研究现状 | |
| 王 茂华, 洪 志鹏 | 567-569 |
| 肺癌分子预后分析 | |
| 崔 永, 王 天佑 | 570-573 |
| 恶性胸膜间皮瘤的诊治进展 | |
| 梁 志欣, 陈 良安 | 574-576 |
Short Communications
| 肿瘤坏死因子对肺癌所致的难治性胸腔积液的疗效观察 | |
| 钟 立松, 赵 雷, 张 仟仕, 蒋 烈洪 | 522 |
Case Reports
| 肺癌合并急性粒-单核细胞性白血病一例 | |
| 赵 艳凤, 姜 达 | 513 |
| 双肺粘液表皮样癌一例报告 | |
| 宫 姝宁, 朴 商, 王 孝廉, 赵 富新, 袁 福祥 | 526 |
| 恶性淋巴瘤合并肺癌一例报告 | |
| 周 黎强, 颜 浩 | 534 |
